CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$1.97
Tradestie Score
65
Market Cap
$149.66M
P/E Ratio
4.9
Revenue Growth
1.1%
Analyst Upside
+133.5%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.78
|
$240.89M | - | 30 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.96
|
$231.77M | - | 53 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.42
|
$227.00M | - | 43 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$12.17
|
$211.22M | - | 50 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.79
|
$202.58M | - | 57 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$1.80
|
$179.47M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.93
|
$158.43M | - | 65 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.44
|
$154.27M | - | 62 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.57
|
$133.50M | - | 51 | Compare |
More CGEN Analysis
Data updated: Oct 28, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry